跳至主要内容
临床试验/TCTR20230411002
TCTR20230411002Unknown1 期

The effect of hyoscine butylbromide for shortening active phase of the first stage of labor : Double blind placebo-controlled trial

khonkaen hospital0 个研究点目标入组 120 人开始时间: 2023年4月11日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • Singleton pregnant women >18 years old
  • term pregnancy with a cephalic presentation and planned vaginal delivery

排除标准

  • High risk pregnancy with contraindication to vaginal delivery e.g., placenta previa, Previous uterine surgery, Cephalopelvic disproportion
  • Pregnancy women who received Epidural anesthesia.
  • Pregnancy women with high risk for unstable fetal status e.g., Placental abruption, Meconium stained amniotic fluid, Fetal anomaly, Non reassuring fetal status
  • Pregnancy women with contraindications for hyoscine-N-Butylbromide
  • Pregnancy women who has infection, chronic disease or pregnancy- induced diseases e.g., Maternal fever (Body temperature more than 37.8 degree celcius), Thyroid disease, cardiovascular disease, Autoimmune disease, Gestational diabetes mellitus, Pregnancy induced hypertension.

研究者

发起方
khonkaen hospital

相似试验

The effect of hyoscine butylbromide for shortening... | 临床试验